334 related articles for article (PubMed ID: 27986554)
41. Greater T Regulatory Cells in Females Attenuate DOCA-Salt-Induced Increases in Blood Pressure Versus Males.
Belanger KM; Crislip GR; Gillis EE; Abdelbary M; Musall JB; Mohamed R; Baban B; Elmarakby A; Brands MW; Sullivan JC
Hypertension; 2020 Jun; 75(6):1615-1623. PubMed ID: 32336228
[TBL] [Abstract][Full Text] [Related]
42. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
[TBL] [Abstract][Full Text] [Related]
43. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
Gao Y; Liu B; Guo X; Nie J; Zou H; Wen S; Yu W; Liang H
J Hypertens; 2023 May; 41(5):794-810. PubMed ID: 36883469
[TBL] [Abstract][Full Text] [Related]
44. Role of substance P in renal injury during DOCA-salt hypertension.
Wang Y; Wang DH
Endocrinology; 2012 Dec; 153(12):5972-9. PubMed ID: 23024265
[TBL] [Abstract][Full Text] [Related]
45. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
[TBL] [Abstract][Full Text] [Related]
46. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
[TBL] [Abstract][Full Text] [Related]
47. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.
Wang D; Luo Y; Myakala K; Orlicky DJ; Dobrinskikh E; Wang X; Levi M
Sci Rep; 2017 Aug; 7(1):9793. PubMed ID: 28851937
[TBL] [Abstract][Full Text] [Related]
48. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
Silambarasan T; Raja B
Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
[TBL] [Abstract][Full Text] [Related]
49. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
[TBL] [Abstract][Full Text] [Related]
50. ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats.
Callera GE; Montezano AC; Touyz RM; Zorn TM; Carvalho MH; Fortes ZB; Nigro D; Schiffrin EL; Tostes RC
Hypertension; 2004 Apr; 43(4):872-9. PubMed ID: 14993193
[TBL] [Abstract][Full Text] [Related]
51. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
[TBL] [Abstract][Full Text] [Related]
52. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
[TBL] [Abstract][Full Text] [Related]
53. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
[TBL] [Abstract][Full Text] [Related]
54. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
Theriot JA; Passmore JC; Jimenez AE; Fleming JT
J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
[TBL] [Abstract][Full Text] [Related]
55. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
[TBL] [Abstract][Full Text] [Related]
56. The protective effect of Bergamot Polyphenolic Fraction on reno-cardiac damage induced by DOCA-salt and unilateral renal artery ligation in rats.
Carresi C; Cardamone A; Coppoletta AR; Caminiti R; Macrì R; Lorenzo F; Scarano F; Mollace R; Guarnieri L; Ruga S; Nucera S; Musolino V; Gliozzi M; Palma E; Muscoli C; Volterrani M; Mollace V
Biomed Pharmacother; 2024 Feb; 171():116082. PubMed ID: 38242036
[TBL] [Abstract][Full Text] [Related]
57. Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats.
Cabral AM; da Silva IF; Gardioli CR; Menegaz RG
Auton Neurosci; 2000 Aug; 82(3):146-53. PubMed ID: 11023621
[TBL] [Abstract][Full Text] [Related]
58. Brain endoplasmic reticulum stress mechanistically distinguishes the saline-intake and hypertensive response to deoxycorticosterone acetate-salt.
Jo F; Jo H; Hilzendeger AM; Thompson AP; Cassell MD; Rutkowski DT; Davisson RL; Grobe JL; Sigmund CD
Hypertension; 2015 Jun; 65(6):1341-8. PubMed ID: 25895586
[TBL] [Abstract][Full Text] [Related]
59. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice.
Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS
Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663
[TBL] [Abstract][Full Text] [Related]
60. Increased sensitivity of the obese Zucker rat to deoxycorticosterone-salt-induced hypertension.
Morrison RG; Carpenter AB; Moore SK; Mangiarua EI; Valentovic MA; Walker EM; Wehner PS; Rhoten WB; Touchon RC; McCumbee WD
J Hypertens; 2002 Nov; 20(11):2247-55. PubMed ID: 12409964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
